Enterprise of Rosatom State Corporation
Back to website

Industry news

13/11/2013
NNSA Hosts International Nuclear Forensics Workshop with Participants from Ten Countries

The Department of Energy’s National Nuclear Security Administration (NNSA) completed a ten-day nuclear forensics workshop at the Pacific Northwest National Laboratory (PNNL) in Richland, Wash.

11/11/2013
Use of MRI in Diagnosis and Treatment of Prostate Cancer Leads to High Rate of Cure According to Study

the use of magnetic resonance imaging (MRI) in the diagnosis and treatment of prostate cancer indicates a greater than 99 percent rate of cure when combined with high-intensity focused ultrasound (HIFU) treatment.

11/11/2013
SNMMI Applauds FDA Approval of Flutemetamol F-18 Injection (Vizamyl)

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) applauds the U.S. Food and Drug Administration (FDA) for its approval of flutemetamol F-18 injection (Vizamyl) for positron emission tomography (PET) imaging of the brain.

11/11/2013
PET/MRI could be alternative to PET/CT for liver lesions

PET/MRI is more than adequate in characterizing liver lesions and provides greater lesion conspicuity than PET/CT, offering clinicians a powerful alternative for oncology imaging.

11/11/2013
PET: A better tactic for imaging head trauma

Imaging the inflammatory response with PET could provide more information about traumatic brain injury (TBI) than conventional CT and MRI methods.

28/10/2013
PET scans peer into the heart of dementia

What’s bad for your heart is often bad for your brain.

28/10/2013
PET tracer shows potential in understanding CNS drug resistance

C-11 laniquidar appears to be safe for PET imaging and might prove effective for use as a biomarker for expression of multidrug transporters such as P-glycoprotein in the brain, which could shed light on resistance to central nervous system drugs such as those used to treat epilepsy.

28/10/2013
Review explores molecular imaging for PVD

A new review suggests imaging techniques such as PET and SPECT with a variety of tracers can be used to improve the detection of peripheral vascular disease.

28/10/2013
PET/CT data used to create 3D images for surgical planning

Researchers have developed a new approach that uses molecular PET/CT images of patients to create detailed 3D hologram-like displays of human organs for use by surgeons.

28/10/2013
Siemens Receives 2013 North American Frost & Sullivan Award for Company of the Year

Based on its recent analysis of the molecular imaging market, Frost & Sullivan recognizes Siemens Healthcare with the 2013 North American Frost & Sullivan Award for Company of the Year.